Probing low affinity and multivalent interactions with surface plasmon resonance: Ligands for concanavalin A

Journal of the American Chemical Society

Volumn 120, Issue 41, 1998, Pages 10575-10582

  Mann, David A ^a   Kanai, Motomu ^a   Maly, Dustin J ^a   Kiessling, Laura L ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE BINDING PROTEIN; CONCANAVALIN A; GLYCOLIPID;

ANALYTIC METHOD; ARTICLE; BINDING AFFINITY; LIGAND BINDING; MICROCALORIMETRY; PROTEIN BINDING;

EID: 0032556246     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja9818506     Document Type: Article

References (65)

1. Drickamer, K.; Taylor, M. E. Annu. Rev. Cell Biol. 1993, 9, 237-64.
2. Varki, A. Glycobiology 1993, 3, 97-130
3. Kiessling, L. L.; Pohl, N. L. Chem. Biol. 1996, 3, 71-7.
4. Roy, R. Curr. Opin. Struct. Biol. 1996, 6, 692-702.
5. Lee, Y.; Lee, R. Acc. Chem. Res. 1995, 28, 321-7.
6. (a) Mortell, K. H.; Weatherman, R. V.; Kiessling, L. L. J. Am. Chem. Soc. 1996, 118, 2297-8.
7. (b) Mortell, K. H.; Gingras, M.; Kiessling, L. L. J. Am. Chem. Soc. 1994, 116, 12053-4.
8. Sauter, N. K.; Bednarski, M. D.; Wurzburg, B. A.; Hanson, J. E.; Whitesides, G. M.; Skehel, J. J.; Wiley: D. C. Biochemistry 1989, 28, 8388-96.
9. Crocker, P. R.; Feizi, T. Curr, Opin. Struct. Biol. 1996, 6, 679-91.
10. Liang, R.; Yan, L.; Loebach, J.; Ge, M.; Uozumi, Y.; Sekanina, K.; Horan, N.; Gildersleeve, J.; Thompson, C.; Smith, A.; Biswas, K.; Still, W. C.; Kahne, D. Science 1996, 274, 1520-2.
11. (a) van der Merwe, P. A.; Barclay, A. N. Curr. Opin. Immunol. 1996, 8, 257-61.
12. (b) Szabo, A.; Stolz, L.; Granzow, R. Curr. Opin. Struct. Biol. 1995, 5, 699-705.
13. (c) Myszka, D. G. Curr. Opin. Biotechnol. 1997, 8, 50-7.
14. For critical analyses of methods for collecting and analyzing SPR data, see: (a) Schuck, P. Annu. Rev. Biophys. Biomol. Struct. 1997, 26, 541-66. (b) Schuck, P.; Minton, A. P. Trends Biochem. Sci. 1996, 21, 458-60.
15. For critical analyses of methods for collecting and analyzing SPR data, see: (a) Schuck, P. Annu. Rev. Biophys. Biomol. Struct. 1997, 26, 541-66. (b) Schuck, P.; Minton, A. P. Trends Biochem. Sci. 1996, 21, 458-60.
16. For a description of the SPR instrument design and principles of its operation, see: Garland, P. B. Q. Rev. Biophys. 1996, 29, 91-117.
17. Kuziemko, G. M.; Stroh, M.; Stevens, R. C. Biochemistry 1996, 35, 6375-84.
18. Imata, H.; Kubota, K.; Hattori, K.; Masaaki, A.; Jindoh, C. Bioorg. Med. Chem. Lett. 1997, 7, 109-12.
19. (a) MacKenzie, C. R.; Hirama, T.; Deng, S.-J.; Bundle, D. R.; Narang, S. A.; Young, N. M. J. Biol. Chem. 1996, 271, 1527-33.
20. (b) Deng, S.-J.; MacKenzie, C. R.; Hirama, T.; Brosseau, R.; Lowary, T. L.; Young, N. M.; Bundle, D. R.; Narang, S. A. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 4992-6.
21. (c) Rheinnecker, M.; Hardt, C.; Ilag, L. L.; Kufer, P.; Gruber, R.; Hoess, A.; Lupas, A.; Rottenberger, C.; Plückthun, A. J. Immunol. 1996, 157, 2989-97.
22. (a) Shinohara, Y.; Kim, F.; Shimizu, M.; Goto, M.; Tosu, M.; Hasegawa, Y. Eur. J. Biochem. 1994, 223, 189-94.
23. (b) Shinohara, Y.; Sota, H.; Kim, F.; Shimizu, M.; Gotoh, M.; Tosu, M.; Hasegawa, Y. J. Biochemistry 1995, 117, 1076-82.
24. (a) Holmskov, U.; Fischer, P. B.; Rothmann, A.; Hojrup, P. FEBS Lett. 1996, 393, 314-6.
25. (b) Adler, P.; Wood, S. J.; Lee, Y. C.; Lee, R. T.; Petri, W. A. J.; Schnaar, R. L. J. Biol. Chem. 1995, 270, 5164-71.
26. Hayashida, O.; Shimizu, C.; Fujimoto, T.; Aoyama, Y. Chem. Lett. 1998, 1, 13-4.
27. Nicholson, M. W.; Barclay, A. N.; Singer, M. S.; Rosen, S. D.; van der Merwe, P. A. J. Biol. Chem. 1998, 2, 763-70.
28. (a) Gordon, E. J.; Sanders, W. J.; Kiessling, L. L. Nature 1998, 392, 30-1.
29. (b) Manning, D. D.; Strong, L. E.; Hu, X.; Beck, P. J.; Kiessling, L. L. Tetrahedron 1997, 53, 11937-52.
30. (b) Manning, D. D.; Hu, X.; Beck, P.; Kiessling, L. L. J. Am. Chem. Soc. 1997, 119, 3161-2.
31. (c) Schuster, M. C.; Mortell, K. H.; Hegeman, A. D.; Kiessling, L. L. J. Mol. Catal. 1997, 116. 209-16.
32. For a review discussing the synthesis of bioactive molecules using ROMP, see: Kiessling, L. L.; Strong, L. E. In Bioactive Polymers; Fürstner, A., Ed.; Springer-Verlag: New York, in press.
33. For other applications of ROMP to the synthesis of carbohydrate-substituted multivalent ligands, see: (a) Fraser, C.; Grubbs, R. H. Macromolecules 1995, 28, 7248-55. (b) Nomura, K.; Schrock, R. R. Macromolecules 1996, 29, 540-5. For reviews describing other approaches to the synthesis of carbohydrate-substituted materials, see refs 3-5.
34. For other applications of ROMP to the synthesis of carbohydrate-substituted multivalent ligands, see: (a) Fraser, C.; Grubbs, R. H. Macromolecules 1995, 28, 7248-55. (b) Nomura, K.; Schrock, R. R. Macromolecules 1996, 29, 540-5. For reviews describing other approaches to the synthesis of carbohydrate-substituted materials, see refs 3-5.
35. For alternative approaches to the synthesis of multidentate ligands for concanavalin A, see ref 25b and (a) Roy, R.; Page, D.; Perez, S. F.; Bencomo, V. V. Glycoconjugate J. 1998, 15, 251-63 and references therein; (b) Kurita, K.; Kobayashi, M.; Munakata, T.; Ishii, S.; Nishimura, S. H. Chem. Lett. 1994, 2063-6. (c) Lehmann, J.; Weitzel, U. P. Carbohydr. Res. 1996, 294, 65-94. (d) Matsuda, K.; Inazu, T.; Haneda, K.; Mizuno, M.; Yamanoi, T.; Hattori, K.; Yamamoto, K.; Kumagai, H. Bioorg. Med. Chem. Lett. 1997, 7, 2353-6.
36. For alternative approaches to the synthesis of multidentate ligands for concanavalin A, see ref 25b and (a) Roy, R.; Page, D.; Perez, S. F.; Bencomo, V. V. Glycoconjugate J. 1998, 15, 251-63 and references therein; (b) Kurita, K.; Kobayashi, M.; Munakata, T.; Ishii, S.; Nishimura, S. H. Chem. Lett. 1994, 2063-6. (c) Lehmann, J.; Weitzel, U. P. Carbohydr. Res. 1996, 294, 65-94. (d) Matsuda, K.; Inazu, T.; Haneda, K.; Mizuno, M.; Yamanoi, T.; Hattori, K.; Yamamoto, K.; Kumagai, H. Bioorg. Med. Chem. Lett. 1997, 7, 2353-6.
37. For alternative approaches to the synthesis of multidentate ligands for concanavalin A, see ref 25b and (a) Roy, R.; Page, D.; Perez, S. F.; Bencomo, V. V. Glycoconjugate J. 1998, 15, 251-63 and references therein; (b) Kurita, K.; Kobayashi, M.; Munakata, T.; Ishii, S.; Nishimura, S. H. Chem. Lett. 1994, 2063-6. (c) Lehmann, J.; Weitzel, U. P. Carbohydr. Res. 1996, 294, 65-94. (d) Matsuda, K.; Inazu, T.; Haneda, K.; Mizuno, M.; Yamanoi, T.; Hattori, K.; Yamamoto, K.; Kumagai, H. Bioorg. Med. Chem. Lett. 1997, 7, 2353-6.
38. For alternative approaches to the synthesis of multidentate ligands for concanavalin A, see ref 25b and (a) Roy, R.; Page, D.; Perez, S. F.; Bencomo, V. V. Glycoconjugate J. 1998, 15, 251-63 and references therein; (b) Kurita, K.; Kobayashi, M.; Munakata, T.; Ishii, S.; Nishimura, S. H. Chem. Lett. 1994, 2063-6. (c) Lehmann, J.; Weitzel, U. P. Carbohydr. Res. 1996, 294, 65-94. (d) Matsuda, K.; Inazu, T.; Haneda, K.; Mizuno, M.; Yamanoi, T.; Hattori, K.; Yamamoto, K.; Kumagai, H. Bioorg. Med. Chem. Lett. 1997, 7, 2353-6.
39. Hall, D. R.; Cann, J. R.; Winzor, D. J. Anal. Biochem. 1996, 235, 175-84.
40. (a) Weatherman, R. V.; Kiessling, L. L. J. Org. Chem. 1996, 61, 534-8.
41. (b) Weatherman, R. W.; Mortell, K. H.; Chervenak, M.; Kiessling, L. L.; Toone, E. J. Biochemistry 1996, 35, 3619-24 and ref 36.
42. Nieba, L.; Krebber, A.; Plückthun, A. Anal. Biochem. 1996, 234, 155-65.
43. (a) Karlsson, R. Anal. Biochem. 1994, 221, 142-51.
44. (b) Karlsson, R.; Jendeberg, L.; Nilsson, B.; Nilsson, J.; Nygren, P. J. Immunol. Methods 1995, 183, 43-9.
45. (a) Ward, L. D.; Howlett, G. J.; Hammacher, A.; Weinstock, J.; Yasukawa, K.; Simpson, R. J.; Winzor, D. J. Biochemistry 1995, 34, 2901-7.
46. (b) O'Shannessy, D.; Winzor, D. Anal. Biochem. 1996, 236, 275-83.
47. Morelock, M. M.; Ingraham, R. H.; Betageri, R.; Jakes, S. J. Med. Chem. 1995, 38, 1309-18.
48. Heyse, S.; Vogel, H.; Sänger, M.; Sigrist, H. Protein Sci. 1995, 4, 2532-44. For an overview of the generation and applications of synthetic surfaces, see: Mrksich, M.; Whitesides, G. M. Annu. Rev. Biophys. Biomol. Struct. 1996, 25, 55-78.
49. Heyse, S.; Vogel, H.; Sänger, M.; Sigrist, H. Protein Sci. 1995, 4, 2532-44. For an overview of the generation and applications of synthetic surfaces, see: Mrksich, M.; Whitesides, G. M. Annu. Rev. Biophys. Biomol. Struct. 1996, 25, 55-78.
50. For a review, see: Löfås, S. Pure App. Chem. 1995, 67, 829-34.
51. -2). For a more detailed discussion of these measurements, see refs 10-12.
52. (a) Kalinin, N. L.; Ward, L. D.; Winzor, D. J. Anal.Biochem. 1995, 228, 238-44.
53. (b) Harris, S. J.; Jackson, C. M.; Winzor, D. J. Arch. Biochem. Biophys. 1995, 316, 20-3.
54. Attie, A. D.; Raines, R. T. J. Chem. Educ. 1995, 72, 119-24.
55. For example, succinylated Con A which exists as a dimer with binding sites oriented in opposite directions does not engage in multivalent interactions.
56. For a discussion of the chelate effect, see: Page, M. I.; Jencks, W. P. Proc. Natl. Acad. Sci. U.S.A. 1971, 68, 1678-83.
57. For studies exploring cross-linking of concanavalin A in the solid state, see: (a) Mandal, D. K.; Brewer, C. F. Biochemistry 1992, 31, 12602-9. (b) Mandal, D. K.; Brewer, C. F. Biochemistry 1993, 32, 5117-20.
58. For studies exploring cross-linking of concanavalin A in the solid state, see: (a) Mandal, D. K.; Brewer, C. F. Biochemistry 1992, 31, 12602-9. (b) Mandal, D. K.; Brewer, C. F. Biochemistry 1993, 32, 5117-20.
59. Several studies have identified multivalent ligands that are more potent inhibitors of lectin binding to cells than they are of lectin-saccharide binding in solution. The authors have proposed that the multivalent ligands can cross-link the lectins in the cellular environment. For some representative examples, see: (a) Lee, Y. C. In Binding modes of mammalian hepatic Gal/GalNAc receptors; Lee, Y. C., Ed.; John Wiley & Sons: Chicester, U.K., 1989; Vol. 145, pp 80-95. (b) Glick, G. D.; Toogood, P. L.; Wiley: D. C.; Skehel, J. J.; Knowles, J. R. J. Biol. Chem. 1991, 266, 23660-9.
60. Several studies have identified multivalent ligands that are more potent inhibitors of lectin binding to cells than they are of lectin-saccharide binding in solution. The authors have proposed that the multivalent ligands can cross-link the lectins in the cellular environment. For some representative examples, see: (a) Lee, Y. C. In Binding modes of mammalian hepatic Gal/GalNAc receptors; Lee, Y. C., Ed.; John Wiley & Sons: Chicester, U.K., 1989; Vol. 145, pp 80-95. (b) Glick, G. D.; Toogood, P. L.; Wiley: D. C.; Skehel, J. J.; Knowles, J. R. J. Biol. Chem. 1991, 266, 23660-9.
61. Quesenberry, M. S.; Lee, R. T.; Lee, Y. C. Biochemistry 1997, 36, 2724-32.
62. Lee, R. T.; Ichikawa, Y.; Kawasaki, T.; Drickamer, K.; Lee, Y. C. Arch. Biochem. Biophys. 1992, 299, 129-36.
63. Alon, R.; Feizi, T.; Yuen, C.-T.; Fuhlbrigge, R. C.; Springer, T. A. J. Immunol. 1995, 154, 5356-5366.
64. Sanders, W. J.; Gordon, E. J.; Alon, R.; Kiessling, L. L., unpublished results.
65. Sigal, G. B.; Mammen, M.; Dahmann, G.; Whitesides, G. M. J. Am. Chem. Soc. 1996, 118, 8(16), 3789-3800.